SCHEDULE 13G/A: Eventide Asset Management and Affiliates Report 8.17% Stake in Aura Biosciences

Eventide Asset Management, LLC, along with Finny Kuruvilla and Robin C. John, has reported a beneficial ownership of 8.17% in Aura Biosciences, Inc.'s common stock as of December 31, 2024.

Summary

• Eventide Asset Management, LLC, Finny Kuruvilla, M.D. Ph. D., and Robin C. John have filed an Amendment No. 2 to Schedule 13G regarding their beneficial ownership of Aura Biosciences, Inc. common stock.
• As of December 31, 2024, the reporting persons collectively beneficially own 4,080,605 shares of Aura Biosciences, Inc. common stock.
• This ownership represents 8.17% of the issuer's outstanding common stock.
• Eventide Asset Management, LLC, a Delaware limited liability company, acts as the investment adviser to the Eventide Healthcare & Life Sciences Fund, which holds these shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Aura Biosciences, Inc.

Sentiment

Score: 5

Explanation: The document is a factual report of beneficial ownership and does not contain qualitative statements about the company's performance or outlook. The reporting of a significant institutional stake is a neutral event in itself, though it might be interpreted positively by the market.

Positives

• Significant institutional investment by Eventide Asset Management, LLC, holding 8.17% of Aura Biosciences, Inc. common stock.
• The investment is stated to be in the ordinary course of business, indicating a long-term investment strategy rather than an activist one.

Future Outlook

NA

Industry Context

This filing indicates continued or new significant institutional interest in Aura Biosciences, Inc., a company likely operating in the healthcare or life sciences sector, given the name of the fund (Eventide Healthcare & Life Sciences Fund). Such filings are common for publicly traded companies as institutional investors cross ownership thresholds.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by Eventide Asset Management, LLC, a registered investment adviser, may be viewed positively by other shareholders as it indicates confidence from a professional investment entity.

Key Dates

Keywords

Aura Biosciences, Eventide Asset Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Investment Adviser, Healthcare & Life Sciences Fund